Literature DB >> 16897601

Changes in region- and cell type-specific expression patterns of neutral amino acid transporter 1 (ASCT-1) in the anterior cingulate cortex and hippocampus in schizophrenia, bipolar disorder and major depression.

S Weis1, I C Llenos, J R Dulay, N Verma, S Sabunciyan, R H Yolken.   

Abstract

Although, the pathogenetic mechanisms of schizophrenia, bipolar disorder, and major depression are not clearly understood, various neurotransmitter systems are reported to have altered expression patterns of their receptor and transporter proteins. Changes in the expression of the neutral amino acid transporter 1 (ASCT-1) protein in the anterior cingulate gyrus and the hippocampus were investigated using immunohistochemistry and western blotting. A significant decrease in ASCT-1 immunoreactivity in neurons in the cingulate cortex as well as astrocytes of the white matter was seen in schizophrenia. In bipolar disorder and major depression, similar results were seen for neurons. In the hippocampus, there was a striking loss of immunoreactivity on astrocytes, neurons and interneurons in multiple regions in schizophrenia and bipolar disorder, while only minor changes were seen in major depression. The altered expression of ASCT-1 in neurons and astrocytes reflects profound changes in glutamatergic neurotransmission and highlights a significant role of astrocytes in the pathophysiology of neurotransmission in these major psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16897601     DOI: 10.1007/s00702-006-0544-0

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  52 in total

Review 1.  Glutamate receptors and transporters in the hippocampus in schizophrenia.

Authors:  Paul J Harrison; Amanda J Law; Sharon L Eastwood
Journal:  Ann N Y Acad Sci       Date:  2003-11       Impact factor: 5.691

2.  Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains.

Authors:  J T Noga; T M Hyde; M M Herman; C F Spurney; L B Bigelow; D R Weinberger; J E Kleinman
Journal:  Synapse       Date:  1997-11       Impact factor: 2.562

3.  Decreased hippocampal expression of a glutamate receptor gene in schizophrenia.

Authors:  P J Harrison; D McLaughlin; R W Kerwin
Journal:  Lancet       Date:  1991-02-23       Impact factor: 79.321

Review 4.  Physiological and pathophysiological roles of excitatory amino acids during central nervous system development.

Authors:  J W McDonald; M V Johnston
Journal:  Brain Res Brain Res Rev       Date:  1990 Jan-Apr

5.  Increased density of glutamate/N-methyl-D-aspartate receptors in putamen from schizophrenic patients.

Authors:  M I Aparicio-Legarza; B Davis; P H Hutson; G P Reynolds
Journal:  Neurosci Lett       Date:  1998-01-30       Impact factor: 3.046

6.  Distribution of glutamate transporter subtypes during human brain development.

Authors:  O Bar-Peled; H Ben-Hur; A Biegon; Y Groner; S Dewhurst; A Furuta; J D Rothstein
Journal:  J Neurochem       Date:  1997-12       Impact factor: 5.372

7.  Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia.

Authors:  R H Porter; S L Eastwood; P J Harrison
Journal:  Brain Res       Date:  1997-03-21       Impact factor: 3.252

8.  Gene expression of metabotropic glutamate receptor 5 and excitatory amino acid transporter 2 in the schizophrenic hippocampus.

Authors:  T Ohnuma; S Tessler; H Arai; R L Faull; P J McKenna; P C Emson
Journal:  Brain Res Mol Brain Res       Date:  2000-12-28

Review 9.  Expression patterns and regulation of glutamate transporters in the developing and adult nervous system.

Authors:  K D Sims; M B Robinson
Journal:  Crit Rev Neurobiol       Date:  1999

10.  Expressed human hippocampal ASCT1 amino acid transporter exhibits a pH-dependent change in substrate specificity.

Authors:  B K Tamarappoo; K K McDonald; M S Kilberg
Journal:  Biochim Biophys Acta       Date:  1996-03-13
View more
  13 in total

1.  Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis.

Authors:  Giuseppe Mameli; Luciana Poddighe; Alessandra Mei; Elena Uleri; Stefano Sotgiu; Caterina Serra; Roberto Manetti; Antonina Dolei
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

2.  Homer1a protein expression in schizophrenia, bipolar disorder, and major depression.

Authors:  Stefan L Leber; Ida C Llenos; Christine L Miller; Jeannette R Dulay; Johannes Haybaeck; Serge Weis
Journal:  J Neural Transm (Vienna)       Date:  2017-08-16       Impact factor: 3.575

3.  Mutant disrupted-in-schizophrenia 1 in astrocytes: focus on glutamate metabolism.

Authors:  Sofya Abazyan; Eun Ju Yang; Bagrat Abazyan; Meng Xia; Chunxia Yang; Camilo Rojas; Barbara Slusher; Rita Sattler; Mikhail Pletnikov
Journal:  J Neurosci Res       Date:  2014-08-08       Impact factor: 4.164

Review 4.  The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation.

Authors:  Hervé Perron; Alois Lang
Journal:  Clin Rev Allergy Immunol       Date:  2010-08       Impact factor: 8.667

Review 5.  Human endogenous retroviruses and the nervous system.

Authors:  Renée N Douville; Avindra Nath
Journal:  Handb Clin Neurol       Date:  2014

Review 6.  The multiple sclerosis-associated retrovirus and its HERV-W endogenous family: a biological interface between virology, genetics, and immunology in human physiology and disease.

Authors:  Antonina Dolei; Hervé Perron
Journal:  J Neurovirol       Date:  2008-11-26       Impact factor: 2.643

Review 7.  The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders.

Authors:  Rodrigo Machado-Vieira; Husseini K Manji; Carlos A Zarate
Journal:  Neuroscientist       Date:  2009-05-26       Impact factor: 7.519

8.  Increased expression of retinoic acid-induced gene 1 in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression.

Authors:  Johannes Haybaeck; Magdalena Postruznik; Christine L Miller; Jeannette R Dulay; Ida C Llenos; Serge Weis
Journal:  Neuropsychiatr Dis Treat       Date:  2015-02-04       Impact factor: 2.570

9.  Association study of polymorphisms in the neutral amino acid transporter genes SLC1A4, SLC1A5 and the glycine transporter genes SLC6A5, SLC6A9 with schizophrenia.

Authors:  Xiangdong Deng; Noriaki Sagata; Naoko Takeuchi; Masami Tanaka; Hideaki Ninomiya; Nakao Iwata; Norio Ozaki; Hiroki Shibata; Yasuyuki Fukumaki
Journal:  BMC Psychiatry       Date:  2008-07-18       Impact factor: 3.630

Review 10.  Human Endogenous Retroviruses as Pathogenic Factors in the Development of Schizophrenia.

Authors:  Gorjan Slokar; Gregor Hasler
Journal:  Front Psychiatry       Date:  2016-01-11       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.